0001415889-23-004091.txt : 20230303
0001415889-23-004091.hdr.sgml : 20230303
20230303161446
ACCESSION NUMBER: 0001415889-23-004091
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230301
FILED AS OF DATE: 20230303
DATE AS OF CHANGE: 20230303
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trencher Daniel
CENTRAL INDEX KEY: 0001830122
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 23704119
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
form4-03032023_090316.xml
X0306
4
2023-03-01
0001477449
Teladoc Health, Inc.
TDOC
0001830122
Trencher Daniel
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
false
true
false
false
SVP CORPORATE STRATEGY
Common Stock
2023-03-01
4
M
0
4716
A
25124
D
Common Stock
2023-03-02
4
S
0
1950
25.362
D
23174
D
Common Stock
2023-03-02
4
M
0
1004
A
24178
D
Common Stock
2023-03-02
4
M
0
1706
A
25884
D
Common Stock
2023-03-02
4
M
0
430
A
26314
D
Common Stock
2023-03-02
4
M
0
956
A
27270
D
Common Stock
2023-03-02
4
M
0
723
A
27993
D
Common Stock
2023-03-02
4
M
0
365
A
28358
D
Restricted Stock Units
2023-03-01
4
M
0
4716
0
D
Common Stock
4716
9433
D
Restricted Stock Units
2023-03-02
4
M
0
1004
0
D
Common Stock
1004
0
D
Performance Stock Units
2023-03-02
4
M
0
1706
0
D
Common Stock
1706
0
D
Performance Stock Units
2023-03-02
4
M
0
430
0
D
Common Stock
430
0
D
Restricted Stock Units
2023-03-02
4
M
0
956
0
D
Common Stock
956
956
D
Performance Stock Units
2023-03-02
4
M
0
723
0
D
Common Stock
723
722
D
Performance Stock Units
2023-03-02
4
A
0
729
0
A
Common Stock
729
729
D
Performance Stock Units
2023-03-02
4
M
0
365
0
D
Common Stock
365
364
D
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
On March 1, 2022, the reporting person was granted 14,149 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.
On March 2, 2020, the reporting person was granted 3,012 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On March 2, 2021, the reporting person earned 5,120 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2021.
On March 2, 2022, the reporting person earned 859 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2022.
On March 2, 2021, the reporting person was granted 2,868 restricted stock units, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
On March 2, 2022, the reporting person earned 2,168 performance stock units, vesting in three substantially equal annual installments beginning on March 2, 2022.
Each performance stock unit represents a contingent right to receive one share of TDOC common stock.
Performance award amount determined based on metrics in respect of the issuer's financial results over a two-year performance period ending in 2022.
The performance stock units vest in two substantially equal annual installments beginning on March 2, 2023.
On March 2, 2023, the reporting person earned 729 performance stock units, vesting in two substantially equal annual installments beginning on March 2, 2023.
/s/ Adam C. Vandervoort, Attorney-in-Fact
2023-03-03